MAZZOCCHETTI, PETRA
 Distribuzione geografica
Continente #
NA - Nord America 376
EU - Europa 234
AS - Asia 121
Totale 731
Nazione #
US - Stati Uniti d'America 376
IT - Italia 74
IE - Irlanda 66
HK - Hong Kong 34
SG - Singapore 31
RO - Romania 29
VN - Vietnam 23
CN - Cina 22
FR - Francia 19
DE - Germania 10
RU - Federazione Russa 9
KR - Corea 8
FI - Finlandia 6
SE - Svezia 6
CZ - Repubblica Ceca 5
GB - Regno Unito 4
CH - Svizzera 2
LB - Libano 2
AT - Austria 1
GR - Grecia 1
RS - Serbia 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 731
Città #
Chandler 111
Dublin 66
Perugia 40
Hong Kong 34
Bucharest 27
Redmond 26
Altamura 23
Boardman 23
Dong Ket 23
Singapore 22
San Mateo 20
Des Moines 15
Lawrence 14
Medford 14
Princeton 14
Andover 11
Beijing 11
Wilmington 11
Seoul 8
Dallas 6
Los Angeles 6
Falls Church 5
Helsinki 4
Munich 4
Brno 3
Nagold 3
Prato 3
Rome 3
Saint Petersburg 3
Hackney 2
Norwalk 2
Olomouc 2
San Paolo di Civitate 2
Santa Clara 2
Timisoara 2
Ann Arbor 1
Ashburn 1
Cambridge 1
Fairfield 1
Frankfurt am Main 1
Lappeenranta 1
Ludwigshafen am Rhein 1
Moscow 1
Shanghai 1
Totale 574
Nome #
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration 107
Microglial activation and the nitric oxide/cGMP/PKG pathway underlie enhanced neuronal vulnerability to mitochondrial dysfunction in experimental multiple sclerosis 80
Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease 64
Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? 61
Effects of safinamide on the glutamatergic striatal network in experimental Parkinson's disease 51
Lacosamide protects striatal and hippocampal neurons from in vitro ischemia without altering physiological synaptic plasticity 49
From Synaptic Dysfunction to Neuroprotective Strategies in Genetic Parkinson’s Disease: Lessons From LRRK2 48
Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson's disease 47
Low doses of Perampanel protect striatal and hippocampal neurons against in vitro ischemia by reversing the ischemia-induced alteration of AMPA receptor subunit composition 47
Differential effect of FHM2 mutation on synaptic plasticity in distinct hippocampal regions 41
Striatal spreading depolarization: Possible implication in levodopa-induced dyskinetic-like behavior 41
Neuroprotection as a potential therapeutic perspective in neurodegenerative diseases: Focus on antiepileptic drugs 37
Striatal spreading depolarization: Possible implication in levodopa-induced dyskinetic-like behavior 37
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis 35
Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences 33
Locally Synthetized 17-β-Estradiol Reverses Amyloid-β-42-Induced Hippocampal Long-Term Potentiation Deficits 12
Totale 790
Categoria #
all - tutte 3.559
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.559


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202032 0 0 0 0 0 3 4 6 3 12 1 3
2020/202178 0 0 2 0 22 6 2 13 4 3 0 26
2021/2022186 3 16 0 2 5 3 1 33 9 46 34 34
2022/2023294 15 61 4 33 22 39 0 18 91 1 7 3
2023/2024124 5 12 9 2 1 0 33 0 5 6 23 28
2024/202546 8 23 15 0 0 0 0 0 0 0 0 0
Totale 790